In particular, we were interested in the evaluation of the expression levels of the products of VANGL1, EGFR, and SMAD4 based on literature data and on the relationships we observed between the expression of their respective encoding genes and the clinical/pathological characteristics of the study CRC patients. This evidence concerns the gene EGFR and colorectal carcinoma.